Informed  ||| S:0 E:9 ||| JJ
consent ||| S:9 E:16 ||| NN
:  ||| S:16 E:18 ||| :
coronary  ||| S:18 E:27 ||| FW
artery  ||| S:27 E:34 ||| FW
bypass  ||| S:34 E:41 ||| FW
grafting  ||| S:41 E:50 ||| FW
Coronary  ||| S:50 E:59 ||| FW
artery  ||| S:59 E:66 ||| FW
bypass  ||| S:66 E:73 ||| FW
graft  ||| S:73 E:79 ||| FW
surgery  ||| S:79 E:87 ||| FW
( ||| S:87 E:88 ||| -LRB-
CABG ||| S:88 E:92 ||| NNP
)  ||| S:92 E:94 ||| -RRB-
is  ||| S:94 E:97 ||| VBZ
well-documented  ||| S:97 E:113 ||| JJ
procedure ||| S:113 E:122 ||| NN
.  ||| S:122 E:124 ||| .
Despite  ||| S:124 E:132 ||| IN
the  ||| S:132 E:136 ||| DT
increased  ||| S:136 E:146 ||| JJ
prevalence  ||| S:146 E:157 ||| NN
of  ||| S:157 E:160 ||| IN
percutaneous  ||| S:160 E:173 ||| JJ
coronary  ||| S:173 E:182 ||| JJ
intervention  ||| S:182 E:195 ||| NN
( ||| S:195 E:196 ||| -LRB-
PCI ||| S:196 E:199 ||| NNP
) ||| S:199 E:200 ||| -RRB-
,  ||| S:200 E:202 ||| ,
surgical  ||| S:202 E:211 ||| JJ
revascularization  ||| S:211 E:229 ||| NN
will  ||| S:229 E:234 ||| MD
continue  ||| S:234 E:243 ||| VB
to  ||| S:243 E:246 ||| TO
have  ||| S:246 E:251 ||| VB
a  ||| S:251 E:253 ||| DT
major  ||| S:253 E:259 ||| JJ
role  ||| S:259 E:264 ||| NN
in  ||| S:264 E:267 ||| IN
patients  ||| S:267 E:276 ||| NNS
with  ||| S:276 E:281 ||| IN
coronary  ||| S:281 E:290 ||| JJ
artery  ||| S:290 E:297 ||| NN
disease ||| S:297 E:304 ||| NN
.  ||| S:304 E:306 ||| .
As  ||| S:306 E:309 ||| RB
shown  ||| S:309 E:315 ||| VBN
in  ||| S:315 E:318 ||| IN
previous  ||| S:318 E:327 ||| JJ
clinical  ||| S:327 E:336 ||| JJ
studies ||| S:336 E:343 ||| NNS
,  ||| S:343 E:345 ||| ,
physicians  ||| S:345 E:356 ||| NNS
can  ||| S:356 E:360 ||| MD
provide  ||| S:360 E:368 ||| VB
important  ||| S:368 E:378 ||| JJ
information  ||| S:378 E:390 ||| NN
about  ||| S:390 E:396 ||| IN
risk-adjusted  ||| S:396 E:410 ||| JJ
outcomes  ||| S:410 E:419 ||| NNS
to  ||| S:419 E:422 ||| TO
patients ||| S:422 E:430 ||| NNS
.  ||| S:430 E:432 ||| .
A  ||| S:432 E:434 ||| DT
number  ||| S:434 E:441 ||| NN
of  ||| S:441 E:444 ||| IN
databases  ||| S:444 E:454 ||| NNS
have  ||| S:454 E:459 ||| VBP
been  ||| S:459 E:464 ||| VBN
used  ||| S:464 E:469 ||| VBN
to  ||| S:469 E:472 ||| TO
develop  ||| S:472 E:480 ||| VB
risk  ||| S:480 E:485 ||| NN
models  ||| S:485 E:492 ||| NNS
for  ||| S:492 E:496 ||| IN
predicting  ||| S:496 E:507 ||| VBG
morbidity  ||| S:507 E:517 ||| NN
and  ||| S:517 E:521 ||| CC
mortality  ||| S:521 E:531 ||| NN
in  ||| S:531 E:534 ||| IN
patients  ||| S:534 E:543 ||| NNS
undergoing  ||| S:543 E:554 ||| VBG
CABG ||| S:554 E:558 ||| NNP
.  ||| S:558 E:560 ||| .
Patients  ||| S:560 E:569 ||| NNS
must  ||| S:569 E:574 ||| MD
make  ||| S:574 E:579 ||| VB
a  ||| S:579 E:581 ||| DT
choice  ||| S:581 E:588 ||| NN
between  ||| S:588 E:596 ||| IN
CABG  ||| S:596 E:601 ||| NNP
and  ||| S:601 E:605 ||| CC
PCI  ||| S:605 E:609 ||| NNP
based  ||| S:609 E:615 ||| VBN
on  ||| S:615 E:618 ||| IN
physicians ||| S:618 E:628 ||| NNS
'  ||| S:628 E:630 ||| POS
explanations ||| S:630 E:642 ||| NNS
.  ||| S:642 E:644 ||| .
Major  ||| S:644 E:650 ||| JJ
trials  ||| S:650 E:657 ||| NNS
demonstrated  ||| S:657 E:670 ||| VBD
a  ||| S:670 E:672 ||| DT
marked  ||| S:672 E:679 ||| JJ
survival  ||| S:679 E:688 ||| NN
benefit  ||| S:688 E:696 ||| NN
from  ||| S:696 E:701 ||| IN
CABG  ||| S:701 E:706 ||| NNP
among  ||| S:706 E:712 ||| IN
those  ||| S:712 E:718 ||| DT
patients  ||| S:718 E:727 ||| NNS
at  ||| S:727 E:730 ||| IN
high  ||| S:730 E:735 ||| JJ
risk  ||| S:735 E:740 ||| NN
of  ||| S:740 E:743 ||| IN
death  ||| S:743 E:749 ||| NN
from  ||| S:749 E:754 ||| IN
the  ||| S:754 E:758 ||| DT
disease  ||| S:758 E:766 ||| NN
itself  ||| S:766 E:773 ||| PRP
as  ||| S:773 E:776 ||| RB
defined  ||| S:776 E:784 ||| VBN
by  ||| S:784 E:787 ||| IN
the  ||| S:787 E:791 ||| DT
severity  ||| S:791 E:800 ||| NN
of  ||| S:800 E:803 ||| IN
angina ||| S:803 E:809 ||| NN
,  ||| S:809 E:811 ||| ,
number  ||| S:811 E:818 ||| NN
of  ||| S:818 E:821 ||| IN
diseased  ||| S:821 E:830 ||| JJ
vessels ||| S:830 E:837 ||| NNS
,  ||| S:837 E:839 ||| ,
and  ||| S:839 E:843 ||| CC
left  ||| S:843 E:848 ||| VBD
ventricular  ||| S:848 E:860 ||| JJ
function ||| S:860 E:868 ||| NN
.  ||| S:868 E:870 ||| .
However ||| S:870 E:877 ||| RB
,  ||| S:877 E:879 ||| ,
it  ||| S:879 E:882 ||| PRP
is  ||| S:882 E:885 ||| VBZ
not  ||| S:885 E:889 ||| RB
clear  ||| S:889 E:895 ||| JJ
that  ||| S:895 E:900 ||| IN
patients  ||| S:900 E:909 ||| NNS
always  ||| S:909 E:916 ||| RB
receive  ||| S:916 E:924 ||| VB
the  ||| S:924 E:928 ||| DT
correct  ||| S:928 E:936 ||| JJ
information  ||| S:936 E:948 ||| NN
on  ||| S:948 E:951 ||| IN
whether  ||| S:951 E:959 ||| IN
CABG  ||| S:959 E:964 ||| NNP
or  ||| S:964 E:967 ||| CC
PCI  ||| S:967 E:971 ||| NNP
is  ||| S:971 E:974 ||| VBZ
the  ||| S:974 E:978 ||| DT
more  ||| S:978 E:983 ||| RBR
appropriate  ||| S:983 E:995 ||| JJ
procedure ||| S:995 E:1004 ||| NN
.  ||| S:1004 E:1006 ||| .
The  ||| S:1006 E:1010 ||| DT
initial  ||| S:1010 E:1018 ||| JJ
informed  ||| S:1018 E:1027 ||| JJ
consent  ||| S:1027 E:1035 ||| NN
should  ||| S:1035 E:1042 ||| MD
be  ||| S:1042 E:1045 ||| VB
obtained  ||| S:1045 E:1054 ||| VBN
using  ||| S:1054 E:1060 ||| VBG
the  ||| S:1060 E:1064 ||| DT
relevant  ||| S:1064 E:1073 ||| JJ
guidelines  ||| S:1073 E:1084 ||| NNS
by  ||| S:1084 E:1087 ||| IN
an  ||| S:1087 E:1090 ||| DT
independent  ||| S:1090 E:1102 ||| JJ
adviser ||| S:1102 E:1109 ||| NN
.  ||| S:1109 E:1111 ||| .
